Advertisement
week in cancer news
  • March 6: The Week in Cancer News

    Some people with prostate cancer may not need hormone therapy, and colorectal cancer cases shift increasingly to younger adults.

    by Eric Fitzsimmons

  • February 27: The Week in Cancer News

    Prostate cancer tumors contain a high concentration of microplastics, and cervical cancer rates vary by state.

    by Thomas Celona

  • February 20: The Week in Cancer News

    First tumor treating fields device for pancreatic cancer approved, and hair extension products often contain potentially dangerous chemicals.

    by Thomas Celona

  • February 13: The Week in Cancer News

    Misinformation reaches most breast cancer survivors, and the FDA approves a treatment combination for platinum-resistant epithelial ovarian cancer.

    by Eric Fitzsimmons

  • February 6: The Week in Cancer News

    Diets high in ultraprocessed foods increase the risk for death in cancer survivors, and a drug reduces hot flashes in men receiving prostate cancer treatment.

    by Darlene Dobkowski

  • January 30: The Week in Cancer News

    Older adults with metastatic cancer are spending more time at medical appointments, and a biomarker test improves the odds of detecting pancreatic cancer.

    by Marci A. Landsmann

  • January 23: The Week in Cancer News

    A vaccine helps reduce recurrences in melanoma, and a blood test may predict which small cell lung cancer patients will respond to immunotherapy.

    by Thomas Celona

  • January 16: The Week in Cancer News

    Government cuts to research limit options for children with rare cancers, and a study links exercise with lower fatigue for people with colorectal cancer.

    by Eric Fitzsimmons

  • January 9: The Week in Cancer News

    Guidelines now recommend self-administered HPV tests for cervical cancer screening, and adding megestrol to hormone therapy slows tumor growth.

    by Darlene Dobkowski

  • December 19: The Week in Cancer News

    Proton therapy for oropharyngeal cancer increases overall survival, and risk-based screening for breast cancer appears to be as effective as annual screening.

    by Marci A. Landsmann